Pull to refresh
Logo
Daily Brief
Following Why Ranks Sign Up
JX

Jinhua Xu

Dermatologist, Huashan Hospital, Fudan University

Appears in 1 story

Notable Quotes

"Soficitinib monotherapy was efficacious and demonstrated a favorable benefit profile."

Stories

InnoCare's oral eczema pill soficitinib clears late-stage trial

New Capabilities

Lead investigator on the published Phase II study

Millions of people with severe eczema live with relentless itching and raw, inflamed skin. On July 15, 2026, InnoCare Pharma said its once-daily pill, soficitinib, hit the main goal of a late-stage trial in that group.

Updated Yesterday